Based on a review of scientific evidence the FDA has finalized its determination that partially hydrogenated oils (PHOs) the primary dietary source of artificial trans fat in processed foods, do not fit the GRAS specifications for use in human foods. Manufactures will now have 3 years to remove them from their products.
“This action is expected to reduce coronary heart disease and prevent thousands of fatal heart attacks every year,” says FDAs Acting Commissioner Stephen Ostroff, MD.
-Neutraceuticals World, July/Aug. 2015
Since 2005 evidence has been mounting that Alzheimer’s disease is essentially type-3 diabetes. Theories say that the build-up of beta amyloid plaques in the brain in place of normal brain cells, is key contributor to the development of the disease – and insulin resistance may trigger these plaques to develop. Research also suggests that type-2 diabetics lose more brain mass with age than a healthy individual which may contribute to dementia.
Insulin helps regulate neurotransmitters such as those responsible for memory and learning. Therefore, a drop in insulin levels may impair cognition. Some studies indicated a link between lower insulin levels and the risk of Alzheimer’s. Dallas Clouatre, Ph.D. says “Increased consumption of simple carbohydrates leads to blood brain barrier degradation and subsequently damage to the hippocampus.”
In reading this article it would seem to prevent insulin resistance, cut down on your carbs and sugars. Also we have found that Phosphatidyserine (PS100) supports good brain function and also our favorites are lecithin, magnesium, electroltyes specifically formulated for the brain (www.electroblast.com) and a good plant source of essential fatty acids (http://foreveryoungcooperative.com/yesefas.html).
*Whole Foods magazine July 2015 “This is your brain on supplements” by Kaylynn Chiarello-Ebner p18